IP Library › Granted Patent US 11,654,246
Granted Patent B2
US 11,654,246 · App. 16/759,488 · Granted May 23, 2023

Drug delivery device

Inventors: Hugo Revellat (Cambridgeshire, GB); Thomas Mark Kemp (Cambridgeshire, GB); William Timmis (Cambridgeshire, GB)
Assignee: Sanofi
A61M5/3157A61M5/2033A61M5/3243A61M2005/2013A61M2205/581A61M2205/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,654,246
App. No.
16/759,488
Filed
Apr 27, 2020
Granted
May 23, 2023
Kind
B2
Art Unit
3783
USPC
604/192
Abstract

The present specification relates to a drug delivery device including a housing adapted to receive a primary container with a piston, a plunger slidably disposed in the housing and adapted to drive the piston for delivering a medicament, a drive spring pre-loaded between the housing and the plunger so as to urge the plunger in a distal direction, an audible and/or tactile indicator, and a trigger mechanism arranged between the indicator and the plunger. The trigger mechanism is configured to support the indicator in an initial state of the device and during delivery of the medicament and to couple with the plunger to activate the audible and/or tactile indicator at or near an end of delivery.

Claims (34)

1. A drug delivery device comprising:

a housing adapted to receive a container with a piston;

a plunger slidably disposed in the housing and adapted to drive the piston for delivering a medicament;

a drive spring pre-loaded between a proximal portion of the housing and the plunger so as to urge the plunger in a distal direction;

an audible and/or tactile indicator configured to provide an indication to a user at or near an end of delivery of the medicament; and

a trigger mechanism arranged between the audible and/or tactile indicator and the plunger,

wherein the trigger mechanism is configured to

support the audible and/or tactile indicator in an initial state of the drug delivery device and during delivery of the medicament, and

couple with the plunger to activate the audible and/or tactile indicator at or near the end of delivery of the medicament.

2. The drug delivery device according to claim 1 , wherein upon activation of the audible and/or tactile indicator, the audible and/or tactile indicator disengages from support by the trigger mechanism.

3. The drug delivery device according to claim 1 , wherein the trigger mechanism comprises at least one structure resiliently abutting the plunger.

4. The drug delivery device according to claim 3 , wherein the at least one structure protrudes from an indicator holder towards the plunger.

5. The drug delivery device according to claim 3 , wherein the at least one structure protrudes from the housing towards the plunger.

6. The drug delivery device according to claim 3 , wherein the at least one structure has an inclined surface.

7. The drug delivery device according to claim 3 , wherein the at least one structure comprises a proximal inclined end, a distal stepped edge, and/or at least one fin or rib.

8. The drug delivery device according to claim 3 , wherein the plunger provides at least one cut-out adapted to receive the at least one structure at or near the end of delivery of the medicament.

9. The drug delivery device according to claim 8 , wherein the at least one cut-out comprises a lateral inclined edge and/or a distal stepped edge.

10. The drug delivery device according to claim 1 , wherein the trigger mechanism comprises two adjacent structures, and wherein the plunger comprises two correspondingly adjacent cut-outs adapted to receive the two adjacent structures.

11. The drug delivery device according to claim 1 , wherein a needle sleeve is telescopically coupled to the housing and has an inner surface with at least one radially inwardly protruding guide rail extending in parallel to a longitudinal axis.

12. The drug delivery device according to claim 11 , wherein the plunger comprises at least one radially outwardly protruding guide pin configured to engage the at least one radially inwardly protruding guide rail.

13. The drug delivery device according to claim 12 , wherein the at least one radially outwardly protruding guide pin is formed as a protruding boss and/or comprises an inclined distal end.

14. The drug delivery device according to claim 11 , wherein the at least one radially inwardly protruding guide rail is formed as a protruding elongated rib in parallel to the longitudinal axis.

15. The drug delivery device according to claim 1 , comprising the container, wherein the container is prefilled with a drug.

16. The drug delivery device according to claim 1 , wherein the drug delivery device is an auto-injector, a pen-injector, or a syringe.

17. An assembly for a drug delivery device, the assembly comprising:

a plunger adapted to deliver medicament from the drug delivery device;

an audible and/or tactile indicator configured to provide an indication to a user at or near an end of delivery of the medicament from the drug delivery device; and

a trigger mechanism configured to be arranged between the audible and/or tactile indicator and the plunger of the drug delivery device, the trigger mechanism comprising a resilient structure abutting the plunger,

wherein the trigger mechanism is configured to

support the audible and/or tactile indicator in an initial state of the assembly and during delivery of the medicament, and

couple with the plunger to activate the audible and/or tactile indicator at or near the end of delivery of the medicament.

18. The assembly of claim 17 , wherein the resilient structure of the trigger mechanism protrudes from an indicator holder towards the plunger.

19. The assembly of claim 17 , wherein the resilient structure has an inclined surface configured to be guided along the plunger during delivery of the medicament.

20. The assembly of claim 19 , wherein the resilient structure comprises a proximal inclined end, a distal stepped edge, and/or at least one fin or rib.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2020
From: REVELLAT, HUGO; KEMP, THOMAS MARK; TIMMIS, WILLIAM
To: SANOFI
Reel/Frame 052623/0497 →
Priority Claims (1)
EP 17306518 · Nov 3, 2017 · regional
Continuity (1)
Related Publication 20200289764A1 · Sep 17, 2020
Cited By (14)
US 12,303,672 US 12,311,153 US 12,318,592 US 12,329,948 US 12,343,514 US 12,415,042 US 12,420,023 US 12,420,024 US 12,420,025 US 12,420,026 US 12,496,408 US 12,649,033 US 12,708,716 US 12,714,799